Fibroblast growth factor 1 (FGFR1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelination

Neurobiology of Disease

Volumn 45, Issue 1, 2012, Pages 196-205

  Zhou, Yong Xing ^a   Pannu, Ravinder ^a,b   Le, Tuan Q ^a   Armstrong, Regina C ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Qiagen Inc   (United States)

Author keywords

Axon damage; Cuprizone; Demyelination; Differentiation; Fibroblast growth factor; Multiple sclerosis; Oligodendrocyte; Platelet derived growth factor; Progenitor; Regeneration; Remyelination

Indexed keywords

CUPRIZONE; FIBROBLAST GROWTH FACTOR 1; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; CELL DENSITY; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; DRUG MECHANISM; FGFR1 GENE; GENE; GENE DELETION; GENE EXPRESSION; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NERVE REGENERATION; NEUROMODULATION; NONHUMAN; OLIGODENDROCYTE PROGENITOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REMYELINIZATION; SIGNAL TRANSDUCTION; STEM CELL; UPREGULATION;

ANIMALS; AXONS; CELL COUNT; CELL DIFFERENTIATION; CORPUS CALLOSUM; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTOR 1; MICE; MICE, TRANSGENIC; MYELIN SHEATH; OLIGODENDROGLIA; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 81955168006     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.08.004     Document Type: Article

References (32)

1. Aguirre A., et al. A functional role for EGFR signaling in myelination and remyelination. Nat. Neurosci. 2007, 10:990-1002.
2. Armstrong R.C., et al. Endogenous cell repair of chronic demyelination. J. Neuropathol. Exp. Neurol. 2006, 65:245-256.
3. Armstrong R.C., et al. Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J. Neurosci. 2002, 22:8574-8585.
4. Bourikas D., et al. LINGO-1-mediated inhibition of oligodendrocyte differentiation does not require the leucine-rich repeats and is reversed by p75(NTR) antagonists. Mol. Cell. Neurosci. 2010, 45:363-369.
5. Doerflinger N.H., et al. Inducible site-specific recombination in myelinating cells. Genesis 2003, 35:63-72.
6. Fortin D., et al. Distinct fibroblast growth factor(FGF)/FGF receptor signaling pairs initiate diverse cellular responses in the oligodendrocyte lineage. J. Neurosci. 2005, 25:7470-7479.
7. Fuss B., et al. Purification and analysis of in vivo-differentiated oligodendrocytes expressing the green fluorescent protein. Dev. Biol. 2000, 218:259-274.
8. Gould J., et al. Comparative gene marker selection suite. Bioinformatics 2006, 22:1924-1925.
9. Itoh N., Ornitz D.M. Functional evolutionary history of the mouse Fgf gene family. Dev. Dyn. 2008, 237:18-27.
10. Lee X., et al. NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. J. Neurosci. 2007, 27:220-225.
11. Liu L., et al. CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis. Nat. Neurosci. 2010, 13:319-326.
12. Lobe C.C., et al. Z/AP, a double reporter for cre-mediated recombination. Dev. Biol. 1999, 208:281-292.
13. Lucchinetti C., et al. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 1999, 122:2279-2295.
14. Mason J.L., et al. Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre. Neuropathol. Appl. Neurobiol. 2001, 27:50-58.
15. Mason J.L., et al. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am. J. Pathol. 2004, 164:1673-1682.
16. Messersmith D.J., et al. Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J. Neurosci. Res. 2000, 62:241-256.
17. Mi S., et al. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann. Neurol. 2009, 65:304-315.
18. Murtie J.C., et al. In vivo analysis of oligodendrocyte lineage development in postnatal FGF2 null mice. Glia 2005, 49:542-554.
19. Murtie J.C., et al. PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol. Dis. 2005, 19:171-182.
20. Nait-Oumesmar B., et al. The role of SVZ-derived neural precursors in demyelinating diseases: from animal models to multiple sclerosis. J. Neurol. Sci. 2008, 265:26-31.
21. Pirvola U., et al. FGFR1 is required for the development of the auditory sensory epithelium. Neuron 2002, 35:671-680.
22. Prendaj E., et al. FGF-2 is not a prototypic member of the FGF family that regulates oligodendrocyte lineage cells. ASN Neuro. Trans. Am. Soc. Neurochem. 2010, PTW07-14.
23. Redwine J.M., Armstrong R.C. In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination. J. Neurobiol. 1998, 37:413-428.
24. Reich M., et al. GenePattern 2.0. Nat. Genet. 2006, 38:500-501.
25. Rubin J.S., et al. Keratinocyte growth factor. Cell Biol. Int. 1995, 19:399-411.
26. Tallquist M.D., Soriano P. Cell autonomous requirement for PDGFRalpha in populations of cranial and cardiac neural crest cells. Development 2003, 130:507-518.
27. Tobin J.E., et al. Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (fgf2)-null mice: differential detection with diffusion tensor imaging. J. Neuropathol. Exp. Neurol. 2011, 70:157-165.
28. Wu Q.Z., et al. MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model. J. Magn. Reson. Imaging 2008, 27:446-453.
29. Xie M., et al. Rostro-caudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlation with pathological features. J. Neuropathol. Exp. Neurol. 2010, 69:704-716.
30. Zhang Y., et al. Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:19162-19167.
31. Zhou Y.X., Armstrong R.C. Interaction of fibroblast growth factor 2 (FGF2) and notch signaling components in inhibition of oligodendrocyte progenitor (OP) differentiation. Neurosci. Lett. 2007, 421:27-32.
32. Zhou Y.X., et al. Retroviral lineage analysis of fibroblast growth factor receptor signaling in FGF2 inhibition of oligodendrocyte progenitor differentiation. Glia 2006, 54:578-590.